Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorUniversity of Graz
About this trial
This study aims to evaluate the effectiveness of Technogyms BioStrength equipment compared to traditional strength training equipment over a 12-week intervention period. The study will determine whether BioStrength machines produce more effective results in terms of muscle strength and body composition. Participants will be allocated to either the BioStrength group or the traditional training group using a minimisation technique to balance important prognostic factors such as handgrip strength, age and gender between the groups. Key measurements include maximum strength tests (10RM) for leg press and chest press, handgrip strength using a dynamometer, and body composition using bioimpedance analysis. Circumference measurements will also be taken. The study will assess whether BioStrength equipment provides superior results in muscle strength, body composition and training efficiency compared to conventional gym equipment.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• Age between 30 and 65 years
Healthy individuals without significant medical conditions
Less than 6 months of prior strength training experience
Willing and able to participate in a 12-week training program
Disqualifiers
• History of coronary heart disease
History of stroke
Need for changes in antihypertensive treatment within 3 months prior to study start
Arthritis
Trial design
Design model
Parallel
Treatments tested in this trial
BioStrength Intervention
DeviceParticipants in the Intervention Group will undergo BioStrength training using Technogym equipment. The intervention will last for 12 weeks, with sessions conducted 3 times per week
Conventional training
DeviceParticipants in the Active Comparator group will undergo a conventional strength training program using standard gym machines. Training sessions will occur 3 times per week for 12 weeks. The goal is to compare the outcomes of BioStrength training with traditional strength training.
Treatment groups
42 Participants
are divided into 2 treatment groupsGroup A: Control Group (No BioStrength Training)Active comparator 1 intervention
Group B: BioStrength trainingExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Skeletal Muscle Mass
Skeletal muscle mass will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to evaluate changes in muscle mass.
Time frame
Baseline and Week 122
Change in Body Fat Percentage
Body fat percentage will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to assess reductions in body fat.
Time frame
Baseline and Week 123
Change in Handgrip Strength
Handgrip strength will be measured using a Jamar dynamometer, with measurements taken at baseline and after the 12-week intervention.
Time frame
Baseline and Week 124
Change in Maximal Strength (10-RM Test)
Maximal strength will be measured using the 10-RM (Repetition Maximum) test for the leg press and chest press exercises at baseline and after the 12-week intervention.
Time frame
Baseline and Week 12Secondary outcomes
1
Customer Satisfaction (CSAT Questionnaire)
Customer satisfaction with the training experience will be measured using a standardized CSAT questionnaire at the end of the 12-week intervention.
Time frame
Week 2 and Week 122
Change in Circumference Measurements (Arm, Leg, and Waist)
Circumference measurements of the arms, legs, and waist will be taken at baseline and after the 12-week intervention to assess changes in muscle size and fat distribution.
Time frame
Baseline and Week 12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov